NSE · JHS
JHS Svendgaard Laboratories Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹30 Cr with net profit ₹1 Cr — a 3.59% net margin, versus -10.92% the period before.
Shareholding
As of 2026-06-30
- Promoter33.85%
- Public63.01%
- FII3.14%
25,150 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.22× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Personal Care - Indian · ranked #10 of 14 by market cap · medians across 12 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Lenskart Solutions Ltd. | ₹1,20,586 Cr | 182.93 | 13.8 | 5.65% | 6.8% |
| Godrej Consumer Products Ltd. | ₹89,017 Cr | 42.87 | 7.04 | 14.71% | 12.05% |
| Dabur India Ltd. | ₹66,781 Cr | 33.67 | 5.85 | 16.59% | 14.55% |
| Cupid Limited | ₹37,308 Cr | 272.01 | 82.76 | 24.01% | 30.35% |
| Emami Limited | ₹16,188 Cr | 21.37 | 5.54 | 26.51% | 19.12% |
| Jyothy Labs Limited | ₹7,185 Cr | 19.62 | 3.51 | 18.07% | 13.01% |
| Bajaj Consumer Care Ltd. | ₹6,850 Cr | 30.72 | 9.07 | 25.24% | 18.05% |
| Radix Industries (India) Ltd. | ₹201 Cr | 68.56 | 8.61 | 13.72% | 6.41% |
| Thrive Future Habitats Limited | ₹97 Cr | — | 2.13 | -1.94% | -132.28% |
| JHS Svendgaard Laboratories Ltd.(this company) | ₹70 Cr | — | 0.4 | -1.1% | -1.74% |
AI analysis
AI-generated · google/gemini-2.5-flashJHS Svendgaard Laboratories Ltd. is listed on the Indian markets with a market capitalization of Rs 65 Cr. The company reported revenue of Rs 94.87 Cr and an EPS of -Rs 2.31. Its 52-week trading range has been between Rs 6.26 and Rs 13.9.
Positives
- +The company has a low debt-to-equity ratio of 0.03.
- +Promoter holding of 33.85% is not pledged.
Negatives
- −The company reported a negative EPS of -Rs 2.31.
- −Return on Capital Employed (ROCE) is negative at -0.75%, indicating inefficient use of capital.
- −Net profit for the year ending March 2025 was negative at -Rs 19.74 Cr.
- −The promoter holding decreased from an unspecified value to 33.85% between March 2017 and June 2026 (exact former value not provided, but history shows changes).
Financial Performance
For the financial year ending March 2025, JHS Svendgaard Laboratories Ltd. reported a revenue of Rs 94.87 Cr. The company recorded a net loss of Rs 19.74 Cr in the same period, with an EPS of -Rs 2.37. Quarterly revenue for March 2026 was Rs 32.7 Cr, with a net loss of Rs 3.57 Cr.
Profitability & Returns
The company's Return on Capital Employed (ROCE) stands at -0.75%. The Enterprise Per Share (EPS) for the latest reported period is -Rs 2.31, indicating a loss per share. The company has not reported a positive Return on Equity (ROE).
Balance Sheet
JHS Svendgaard Laboratories Ltd. has a Book Value per share of Rs 19.89. The debt-to-equity ratio is 0.03, suggesting a low reliance on debt for financing. Further details regarding other assets and liabilities are not available in the provided data.
Ownership & Pledges
As of June 30, 2026, promoter holding in JHS Svendgaard Laboratories Ltd. was 33.85%. Public shareholding was 63.01%. Foreign Institutional Investors (FIIs) held 3.14% of the shares. There were no promoter pledges reported.
Data as of — price: 2026-09-10 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to JHS Svendgaard Laboratories Ltd.share price & fundamentals